Microbiome Therapeutics for Humans

Therapeutics targeting ways to influence the human microbiome to either treat or prevent disease has been of substantially growing interest in the past decade, and as of late, with a lot of financing activity to back it up.  Human microbiome therapeutics may hold the key to treating many infections, diseases and conditions today for which there are few good treatment options or where antibiotics are no longer viable.

Each month our analyst team reviews an emerging trend with interested listeners — alternating between Healthcare and Agriculture — outlining macro-trends, industry sub-sectors, key influencers, market leaders, and potential investment opportunities. Register here.